Pediatrix Medical
229 hedge funds and large institutions have $1.08B invested in Pediatrix Medical in 2024 Q4 according to their latest regulatory filings, with 35 funds opening new positions, 80 increasing their positions, 74 reducing their positions, and 22 closing their positions.
2,161% more call options, than puts
Call options by funds: $701K | Put options by funds: $31K
59% more first-time investments, than exits
New positions opened: 35 | Existing positions closed: 22
8% more capital invested
Capital invested by funds: $995M → $1.08B (+$84.6M)
5% more funds holding
Funds holding: 218 → 229 (+11)
8% more repeat investments, than reductions
Existing positions increased: 80 | Existing positions reduced: 74
4.29% less ownership
Funds ownership: 100.11% → 95.82% (-4.3%)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
Top Sellers
| 1 |
RCMNY
Rubric Capital Management (New York)
New York
|
-$70.8M |
| 2 |
Morgan Stanley
New York
|
-$29.8M |
| 3 |
WAM
Weiss Asset Management
Boston,
Massachusetts
|
-$10.6M |
| 4 |
AllianceBernstein
Nashville,
Tennessee
|
-$10.5M |
| 5 |
ICM
Invenomic Capital Management
Boston,
Massachusetts
|
-$9.05M |
MD Hedge Fund Activity: Q4 2024 in Review
229 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Pediatrix Medical (MD) for Q4 2024, worth a combined $1.08B — up 8.5% from $995M a quarter earlier.
Buyers outnumbered sellers: 35 funds opened new MD positions and 22 closed out — a net gain of 13 holders — while 80 added to existing stakes and 74 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $40M. The largest seller was Rubric Capital Management (New York), cutting an estimated $70.8M.
- 229 institutional investors held Pediatrix Medical (MD) as of Q4 2024, up from 218 in Q3 2024.
- Funds reported $1.08B of Pediatrix Medical stock for Q4 2024, up 8.5% quarter-over-quarter.
- 35 funds opened new Pediatrix Medical positions in Q4 2024 and 22 closed out, a net change of +13 holders.
- The largest Pediatrix Medical buyer in Q4 2024 was Fidelity Investments, an estimated $40M added.
- The largest Pediatrix Medical seller in Q4 2024 was Rubric Capital Management (New York), an estimated $70.8M sold.
Based on aggregated 13F filings for Q4 2024.